Overview

Study of 68Ga-R10602

Status:
RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.
Phase:
PHASE1
Details
Lead Sponsor:
Radionetics Oncology